Ticker LaunchReverse merger · Completed · PTPI
Metuchen Pharmaceuticals LLC
Reverse merger with Neurotrope, Inc. (NTRP)
Metuchen Pharmaceuticals LLC merged into Neurotrope, Inc. (NTRP), a Nasdaq-listed biotech that spun out its legacy assets before the merger, in a reverse merger that takes the private company public. The deal was announced on May 17, 2020 and closed on Dec 2, 2020. The combined company trades as Petros Pharmaceuticals, Inc. (PTPI) on Nasdaq.
Petros Pharmaceuticals, Inc. is a pharmaceutical company that markets an FDA-approved erectile dysfunction drug and pursues non-prescription strategies for it, with a pipeline including topical candidate H100 for Peyronie's disease.
- Status
- Completed
- Private company
- Metuchen Pharmaceuticals LLC
- Public company
- Neurotrope, Inc. (NTRP)
- Public company business before
- Nasdaq-listed biotech that spun out its legacy assets before the merger
- Announced
- May 17, 2020
- Closed
- Dec 2, 2020
- Combined company
- Petros Pharmaceuticals, Inc. (PTPI)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Dec 2, 2020
- Closing exhibit
- Announcement 8-K Dec 2, 2020
- All filings on EDGAR CIK 1815903
Other completed reverse mergers
- Eagle Lake Laboratories, Inc.into Sollensys Corp. · Nov 30, 2020
- Powertech Holdings Company Limitedinto Folkup Development Inc. · Nov 25, 2020
- F-star Therapeutics Limitedinto Spring Bank Pharmaceuticals, Inc. · Nov 20, 2020
- MedAvail, Inc.into MYOS RENS Technology Inc. · Nov 18, 2020
- Medi-Scan, Inc.into HYB Holding Corp. · Nov 16, 2020
- West Of Hudson Group, Inc.into Tongji Healthcare Group, Inc. · Nov 12, 2020